Top compounds associated with response to NOL4L


Feature Type Standardized
Nominal ANOVA
mRNA temsirolimus GDSC1000 pan-cancer AAC -0.12 0.0007
mRNA AS605240 GDSC1000 pan-cancer AAC 0.11 0.0007
mRNA YM-155 CTRPv2 pan-cancer AAC -0.13 0.0008
mRNA Doxorubicin CTRPv2 pan-cancer AAC -0.1 0.0009
mRNA GW-2580 GDSC1000 pan-cancer AAC 0.11 0.001
mRNA Rapamycin gCSI pan-cancer AAC -0.19 0.001
mRNA Vinorelbine GDSC1000 pan-cancer AAC -0.11 0.002
mRNA bendamustine CTRPv2 pan-cancer AAC -0.12 0.002
mRNA Genentech Cpd 10 GDSC1000 pan-cancer AAC 0.097 0.002
mRNA Docetaxel gCSI pan-cancer AAC -0.17 0.003
Download CSV